DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease

Google DeepMind launched AlphaGenome, an AI tool that analyses up to one million DNA letters to predict how mutations disrupt gene regulation and cause disease. Trained on human and mouse genetic data, AlphaGenome helps identify mutations linked to cancer, heart disease, and autoimmune disorders. Researchers say it could accelerate drug discovery and gene therapies by revealing how genes switch on and off in specific cells. Scientists from University College London and the University of Exeter called it a major step toward understanding the genome’s non-coding regions.